Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Current studies in myotonic dystrophy].

Brain and nerve = Shinkei kenkyu no shinpo - 1 Mar 2014

Zhao Yimeng, Ishiura Shoichi

Abstract excerpt

Myotonic dystrophy (DM) is a genetic, progressive, multisystemic disease with muscular disorder as its primary symptom. There are two types of DM (DM1 and DM2) caused by mutations in different genes, and in Japan, DM occurs with an incidence of approximately 1 in 20,000. The pathogenic mechanism underlying the disease is RNA toxicity caused by transcripts of aberrantly elongated CTG or CCTG repeats located in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Introns
Share to Mutation
Share to Myotonic Dystrophy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Protein Serine-Threonine Kinases

Source

Identifiers

PMID: 24607950

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Current studies in myotonic dystrophy].PMID 24607950Read ↗

[Myotonic dystrophy: therapeutic approaches to RNA toxicity].Semantic proximity Read ↗

Therapeutics development in myotonic dystrophy type 1Semantic proximity Read ↗

Myotonic dystrophy: approach to therapy.Semantic proximity Read ↗

[Myotonic dystrophy - a new insight into a well-known disease].Semantic proximity Read ↗

Myotonic Dystrophy Type 2: An Update on Clinical Aspects, Genetic and Pathomolecular MechanismSemantic proximity Read ↗

Myotonic dystrophy: RNA pathogenesis comes into focus.Semantic proximity Read ↗

Mitigating RNA Toxicity in Myotonic Dystrophy using Small MoleculesSemantic proximity Read ↗

Small Molecules Which Improve Pathogenesis of Myotonic Dystrophy Type 1Semantic proximity Read ↗

RNA pathogenesis of the myotonic dystrophies.Semantic proximity Read ↗

Myotonic dystrophy, when simple repeats reveal complex pathogenic entities: new findings and future challengesSemantic proximity Read ↗

Perspectives on gene therapy in myotonic dystrophy type 1.Semantic proximity Read ↗

Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.